scoparone has been researched along with Fatty Liver, Nonalcoholic in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 4 (80.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, H; Gao, Y; Guo, K; Huang, X; Li, J; Li, T; Mo, S; Wei, R; Wu, J; Zhang, K | 1 |
| Cao, H; Gao, Y; He, H; Li, T; Lu, H; Novák, P; Wei, M; Yang, C; Yin, Y; Zhang, K | 1 |
| Deng, X; Jiang, Q; Li, G; Liu, B; Xin, S; Xu, K; Zhang, J; Zhang, N | 2 |
| Chen, X; Cui, B; Fan, X; Feng, H; Hui, Y; Lin, L; Mao, L; Sun, C; Wang, B; Wang, X; Yu, Q; Yu, Z; Zhang, J; Zhao, T; Zhao, X | 1 |
1 review(s) available for scoparone and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Scoparone as a therapeutic drug in liver diseases: Pharmacology, pharmacokinetics and molecular mechanisms of action.
Topics: Animals; Artemisia; Coumarins; Drugs, Chinese Herbal; Humans; Liver; Liver Diseases; Medicine, Chinese Traditional; Non-alcoholic Fatty Liver Disease | 2020 |
4 other study(ies) available for scoparone and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Effects of scoparone on non-alcoholic fatty liver disease revealed by RNA sequencing.
Topics: Animals; Coumarins; Fatty Acids; Male; Mice; Non-alcoholic Fatty Liver Disease; Sequence Analysis, RNA; Transaminases; Triglycerides | 2022 |
The effects of scoparone on alcohol and high-fat diet-induced liver injury revealed by RNA sequencing.
Topics: Animals; Antioxidants; Chemical and Drug Induced Liver Injury, Chronic; Cholesterol; Cytochrome P-450 Enzyme System; Diet, High-Fat; Ethanol; Fatty Acids; Lipid Metabolism; Liver; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Sequence Analysis, RNA; Triglycerides; Xenobiotics | 2022 |
Scoparone alleviates inflammation, apoptosis and fibrosis of non-alcoholic steatohepatitis by suppressing the TLR4/NF-κB signaling pathway in mice.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Coumarins; Fibrosis; Liver; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Non-alcoholic Fatty Liver Disease; RAW 264.7 Cells; Signal Transduction; Toll-Like Receptor 4 | 2019 |
Scoparone improves hepatic inflammation and autophagy in mice with nonalcoholic steatohepatitis by regulating the ROS/P38/Nrf2 axis and PI3K/AKT/mTOR pathway in macrophages.
Topics: Animals; Autophagy; Cholagogues and Choleretics; Coumarins; Dose-Response Relationship, Drug; Inflammation; Liver; Macrophages; Male; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Non-alcoholic Fatty Liver Disease; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; RAW 264.7 Cells; Reactive Oxygen Species; Signal Transduction; TOR Serine-Threonine Kinases | 2020 |